Issue 48, 2020

Synthesis and cytotoxicity of (−)-homo-renieramycin G and its derivatives

Abstract

(−)-Homo-renieramycin G and its twenty derivatives were prepared from L-tyrosine methyl ester via a multi-step route. Their cytotoxicities were tested against four human cancer cell lines (A549, HeLa, KB and BGC-823). (−)-Renieramycin G and (−)-homo-renieramycin G showed comparable cytotoxicity against these four cancer cell lines, which indicated that the expansion of ring C from the six-membered 1,4-piperazinone to the seven-membered 1,4-diazepanone had no obvious impact on the cytotoxicity. Compound 42 with methyl side chain and compounds 38–41 with heterocyclic aromatic side chains at C-23 exhibited the most potent cytotoxicity with the IC50 values at the level of 10−6 M.

Graphical abstract: Synthesis and cytotoxicity of (−)-homo-renieramycin G and its derivatives

Supplementary files

Article information

Article type
Paper
Submitted
30 Oct 2020
Accepted
25 Nov 2020
First published
27 Nov 2020

Org. Biomol. Chem., 2020,18, 9883-9894

Synthesis and cytotoxicity of (−)-homo-renieramycin G and its derivatives

Y. Ma, X. Pan, B. Guan, G. Zhang and Z. Liu, Org. Biomol. Chem., 2020, 18, 9883 DOI: 10.1039/D0OB02167A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements